Research Papers

25 of 610 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Differences in transcriptional changes in psoriasis and psoriatic arthritis skin with immunoglobulin gene enrichment in…
Johnsson H; Cole J; McInnes IB; Graham G; Siebert S.
Rheumatology (Oxford) (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCE…
Kaeley GS; Schett G; Conaghan PG; McGonagle D; Behrens F; Goupille P; Gaillez C; Parikh B; Bakewell C.
Rheumatology (Oxford) (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIM…
Baraliakos X; Pournara E; Coates LC; Navarro-Compán V; Blanco R; O'Brien E; Schulz B; Landewe R.
Rheumatology (Oxford) (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
The impact of traditional cardiovascular risk factor control on 7-year follow-up atherosclerosis progression in systemi…
Papazoglou N; Kravvariti E; Konstantonis G; Sfikakis PP; Tektonidou MG.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Paranasal sinus occupancy assessed from magnetic resonance images-associations with clinical indicators in patients wit…
Valdés Hernández MDC; Ferguson KJ; Loon P; Kirkwood G; Zhang JF; Amft N; Ralston SH; Wu YC; Wardlaw JM; Wiseman SJ.
Rheumatology (Oxford) (Unknown)
Published: 2024
4/6 Transparent
Code Funding Declared
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist…
Altabás-González I; Rúa-Figueroa Í; Rubiño F; Mouriño C; Hernández-Rodriguez Í; Menor-Almagro R; Uriarte-Isacelaya E; Tomero E; Salman-Monte TC; Carrión-Barberá I; Galindo-Izquierdo M; Rodriguez-Almaraz ME; Inês LS; Jiménez N; Pego-Reigosa JM.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target.
Bolt JW; Aalbers CJ; Walet L; van Mens LJJ; van Denderen C; van der Horst-Bruinsma I; van Baarsen LGM; Landewé R; van de Sande MGH.
Rheumatology (Oxford) (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Viewpoint: Could better understanding of risk factors for comorbidities pave the way towards personalized therapy in rh…
Majnik J; Nagy G.
Rheumatology (Oxford) (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Viewpoint: how to measure comorbidities in patients with rheumatoid arthritis - clinical and academic value.
Radner H.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Viewpoint: Glucocorticoids in the treatment of rheumatoid arthritis: points to (re)consider.
Boers M.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review.
Ross L; Maltez N; Hughes M; Schoones JW; Baron M; Chung L; Giuggioli D; Moinzadeh P; Suliman YA; Campochiaro C; Allanore Y; Denton CP; Distler O; Frech T; Furst DE; Khanna D; Krieg T; Kuwana M; Matucci-Cerinic M; Pope J; Alunno A.
Rheumatology (Oxford) (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
AI am a rheumatologist: a practical primer to large language models for rheumatologists.
Venerito V; Bilgin E; Iannone F; Kiraz S.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Chronic non-bacterial osteomyelitis in SAPHO syndrome complicated by subclavian vein obstruction.
Leerling AT; Navas Cañete A; Winter EM.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis?
Esperança Almeida D; Smith K; Sarker BA; Barr A; Wakefield RJ; Mackie SL.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cost-effectiveness of cognitive behavioural and personalized exercise interventions for reducing fatigue in inflammator…
Chong HY; McNamee P; Bachmair EM; Martin K; Aucott L; Dhaun N; Dures E; Emsley R; Gray SR; Kidd E; Kumar V; Lovell K; MacLennan G; Norrie J; Paul L; Packham J; Ralston SH; Siebert S; Wearden A; Macfarlane G; Basu N; LIFT Study Group.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
New bone formation at the sacroiliac joint in axial spondyloarthritis: characterization of backfill in MRI and CT.
Diekhoff T; Poddubnyy D; Proft F; Ziegeler K; Deppe D; Niedermeier C; Hermann KGA.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease acti…
Backström M; Tarkiainen M; Gottlieb BS; Trincianti C; Qiu T; Morgan E; Lovell DJ; Bovis F; Löyttyniemi E; Ruperto N; Vähäsalo P; Consolaro A.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Improving access to SLE therapies in low and middle-income countries.
Mendoza-Pinto C; Etchegaray-Morales I; Ugarte-Gil MF.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The global epidemiology of SLE: narrowing the knowledge gaps.
Barber MRW; Falasinnu T; Ramsey-Goldman R; Clarke AE.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Health inequalities and systemic lupus erythematosus: a global challenge.
Bruce IN.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever.
Sener S; Cam V; Batu ED; Kasap Cuceoglu M; Balik Z; Aliyev E; Bayindir Y; Basaran O; Bilginer Y; Ozen S.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Metabolic and inflammatory profiles define phenotypes with clinical relevance in female knee osteoarthritis patients wi…
Calvet J; García-Manrique M; Berenguer-Llergo A; Orellana C; Cirera SG; Llop M; Galisteo Lencastre C; Arévalo M; Aymerich C; Gómez R; Giménez NA; Gratacós J.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatmen…
Weinstein CLJ; Sliwinska-Stanczyk P; Hála T; Stanislav M; Tzontcheva A; Yao R; Berd Y; Curtis SP; Philip G.
Rheumatology (Oxford) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicen…
Chen X; Quan R; Qian Y; Yang Z; Yu Z; Zhang C; Yang Y; Zhang G; Shen J; Wang Q; Gu Q; Xiong C; Jing X; Han H; He J.
Rheumatology (Oxford) (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: internat…
Bridgewater S; Shepherd MA; Dawson J; Richards P; Silverthorne C; Ndosi M; Almeida C; Black RJ; Cheah JTL; Dures E; Ghosh N; Hoon EA; Lyne S; Navarro-Millan I; Pearce-Fisher D; Ruediger C; Tieu J; Yip K; Mackie SL; Goodman S; Hill C; Robson JC.
Rheumatology (Oxford) (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared